AIVITA Biomedical, Inc.

[On Demand]
AIVITA Biomedical, Inc. is a personalized vaccine company evaluating vaccines for prevention of COVID-19 infection and treatment of cancer. Our immuno-oncology vaccine therapies address the seed of all cancers, tumor-initiating cells, with a unique pan-antigenic approach that targets all neoantigens to overcome a cancer’s tendency to mutate over time. Our patient-specific treatments have shown tremendous promise in eradicating tumors without harmful side effects in our melanoma and glioblastoma clinical studies.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Cancer Immunotherapy
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Chairman & CEO
AIVITA Biomedical, Inc.